Published in Gene Therapy Weekly, January 19th, 2006
In a recent article published in the journal Clinical Cancer Research, scientists in Spain detailed a study conducted "to evaluate the efficacy of reduced intensity conditioning (RIC) allogeneic transplant in 30 patients with poor-prognosis CLL and/or high-risk molecular/cytogenetic characteristics. Eighty-three percent of patients had active disease at the moment of transplant."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.